Skip to main content

Bradbury Daniel's Form 4 filing

Castle Biosciences Inc (CSTL) · filed Feb 11, 2022

Accession no.
0001447362-22-000026
Filed
Feb 11, 2022
Trade date
Feb 9-10, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions. Open-market sales total $814.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bradbury DanielCIK 0001236397Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 9, 2022Common StockSSaleDisposed−3,852$46.33F2−$178,463.16212,216Indirect
Feb 9, 2022Common StockSSaleDisposed−2,500$46.73F4−$116,825115,037Indirect
Feb 9, 2022Common StockSSaleDisposed−2,500$46.64F6−$116,600115,062Indirect
Feb 10, 2022Common StockSSaleDisposed−3,384$44.42F8−$150,317.28208,832Indirect
Feb 10, 2022Common StockSSaleDisposed−468$45.13F9−$21,120.84208,364Indirect
Feb 10, 2022Common StockSSaleDisposed−2,500$45.88F10−$114,700112,537Indirect
Feb 10, 2022Common StockSSaleDisposed−2,500$46.52F11−$116,300112,562Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $45.850 to $46.830, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $46.500 to $47.040, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $46.370 to $46.870, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $44.010 to $45.000, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $45.070 to $45.210, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $45.210 to $46.190, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F11

This transaction was executed in multiple trades at prices ranging from $46.190 to $46.925, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)